EIF2AK3 and colorectal carcinoma: In contrast, inhibition of PERK by the small molecule inhibitor GSK2656157, or the related GSK2606414, does not specifically affect the viability of APC-deficient CRC cells or murine intestinal organoids [12,199,200].